Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Letter

Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis

Online download statistics by month:

Online download statistics by month: October 2020 to December 2022

	Abstract	Full	Pdf
Oct 2020	550	550	139
Nov 2020	604	603	132
Dec 2020	166	166	92
Jan 2021	111	110	41
Feb 2021	93	93	25
Mar 2021	433	432	92
Apr 2021	188	186	61
May 2021	127	122	40
Jun 2021	105	102	39
Jul 2021	100	100	33
Aug 2021	90	88	46
Sep 2021	81	80	41
Oct 2021	117	108	55
Nov 2021	74	74	42
Dec 2021	94	94	43
Jan 2022	82	82	29
Feb 2022	50	54	21
Mar 2022	59	57	15
Apr 2022	95	103	30
May 2022	85	89	30
Jun 2022	85	82	25
Jul 2022	62	59	17
Aug 2022	59	59	23
Sep 2022	78	74	34
Oct 2022	92	89	29
Nov 2022	58	59	16
Dec 2022	57	57	25
Total	3795	3772	1215